Search Results 2171-2180 of 43872 for oral

  1. Testing The Addition Of M3814 (Peposertib) To Radiation Therapy For Patients With Advanced Head And Neck Cancer Who Cannot Take Cisplatin - Mayo Clinic

    ... oral cavity cancer are excluded from participation if the patient is medically operable and the resection of the primary tumor is considered technically ...

  2. Podofilox (topical route) - Side effects & dosage - Mayo Clinic

    oral ulcers. Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to ...

  3. Follicular Lymphoma Clinical Trials - Mayo Clinic Research

    Venetoclax is an oral Bcl-2 family protein inhibitor. ... However, single drug therapies have limitations, therefore, the current study is evaluating a novel oral ...

  4. Bezlotoxumab (MK-6072) Versus Placebo In Children With Clostridium Difficile Infection (CDI) (MK-6072-001) - Mayo Clinic

    ... oral vancomycin, oral metronidazole, or oral fidaxomicin. Additionally, IV metronidazole may be given concurrently with oral vancomycin or oral fidaxomicin.

  5. Sarcoma - Doctors and departments - Mayo Clinic

    John M. Nathan, M.D.,D.D.S.. Surgeon; Sleep Medicine Specialist; Oral and Maxillofacial Surgeon. Rochester, MN ...

  6. Acyclovir (topical route) - Side effects & dosage - Mayo Clinic

    Topical acyclovir is used to treat the symptoms of herpes simplex virus infections of the skin, mucous membranes, and genitals (sex organs). Although topical ...

  7. Mayo Clinic Q and A: Defining head and neck cancer

    DEAR MAYO CLINIC: A co-worker recently was diagnosed with oral cancer after a nagging cough led him to the doctor. It got me wondering about the incidence ...

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  9. Nonmelanoma skin cancer - Doctors and departments - Mayo Clinic

    Kyle S. Ettinger, M.D., D.D.S.. Surgical Oncologist; Oral and Maxillofacial Surgeon. Rochester, MN ...

  10. A Study To Assess Effectiveness And Safety Of SER‑287 In Adults With Active Mild-to-Moderate Ulcerative Colitis - Mayo Clinic

    oral AZA (≥ 1.5 mg/kg/day) or 6-MP (≥ 0.75 mg/kg/day); or; oral AZA or 6-MP within a therapeutic range, as judged by thioguanine metabolite testing; or; a ...